In this study, we demonstrated the existence of soluble ectodomain of the human LRIG3, and reported that LRIG3 and its soluble ectodomain, sLRIG3, inhibited glioma progression through the regulation of the MET/PI3K/Akt pathway both in vitro and in vivo. Here, LRIG3 is linked to central nervous system cancer.